BOUT
Innovator IBD Breakout Opportunities ETF
The innovator IBD Breakout Opportunities ETF tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors. The fund may hold 50% T-bills based on technical market signals.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 13.8 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Inception date | Sep 12, 2018 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| EAGLE BANCORP INC | 7.5 % |
| CROCS INC | 7.5 % |
| HASBRO INC | 7.4 % |
| COCA-COLA BOTTLING CO CONSOL | 7.3 % |
| ESQUIRE FINANCIAL HOLDINGS, INC. | 6.6 % |
| RINGCENTRAL, INC. CLASS A | 6.6 % |
| MOODY'S CORP | 6.5 % |
| ASTRAZENECA PLC | 6.4 % |
| BALL CORP | 6.3 % |
| OKTA, INC. CLASS A | 5.2 % |
Constituent Breakdown
| Number of holdings | 24 |
| Herfindahl-Hirschman Index | 549 |
| Wgt avg mkt cap (mns) | $34,804 |
| Large cap (>$10bn) | 53.5% |
| Mid cap ($2-10bn) | 28.8% |
| Small cap (<$2bn) | 16.8% |
| Developed mkts. | 99.2% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 87.0 % |
 |
BRITAIN | 6.4 % |
 |
DENMARK | 4.0 % |
 |
GREECE | 1.8 % |
Historical Performance
Standardized Performance (as of 10/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 11.9% | 7.5% | 5.3% | 11.9% | 2.1% | -- | -- | 6.2% |
| Dividend Yield | 0.0% | 0.0% | 0.3% | 0.7% | 0.7% | -- | -- | 0.5% |
| Total Returns | 11.9% | 7.5% | 5.6% | 12.6% | 2.8% | -- | -- | 6.7% | Ann. Volatility | 22.6% | 22.2% | 21.5% | 19.8% | 19.8% | -- | -- | 22.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.24 | 51% |
| MSCI EAFE | 0.92 | 43% |
| MSCI Emg Mkts | 0.59 | 46% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.55% |
Technical Indicators
| 30d moving avg. (EMA) | $41.54 |
| Relative strength (RSI) | 35 |
| MACD/Signal | -0.91/-0.70 |
| Bollinger Bands (Upper/Lower) | $43.35/$39.01 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. BOUT |
Expenses vs. BOUT |
ALTAR Score™ vs. BOUT |
|---|---|---|---|---|
| FFTY | Innovator IBD 50 ETF | 25.2% | +23 bp | -0.4% |
| SAMM | Strategas Macro Momentum ETF | 10.6% | +27 bp | -1.4% |
Risk and Returns: BOUT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/11/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.5%
ALTAR SCORE™
67th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,439 funds in the US Equity category with an average
ALTAR Score™ of 5.6% and a standard deviation
of 2.1%. BOUT's ALTAR Score™ is approximately 0.5 standard
deviations above the category average. This places BOUT in the 67th percentile
among funds in the category.
Sell-Side Consensus
$42.29
PRICE TARGET
+7.2%
UPSIDE